Chris A Rallis Fennec Pharmaceuticals Inc. (FENC) insider trading activity

Chris A Rallis is of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 57,079 shares of FENC, which is worth approximately $469,189. The most recent transaction as insider was on Oct 10, 2025, when has been sold 1,775 shares (Common Shares) at a price of $9.24 per share, resulting in proceeds of $16,401. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.1K

4.17% 3M change

17.39% 12M change

Total Value Held $469,189

CHRIS A RALLIS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2025	SELL Open market or private sale	$16,401 $9.24 p/Share	1,775 Reduced 3.02%	57,079 Common Shares
Oct 10 2025	BUY Exercise of conversion of derivative security	$4,996 $1.23 p/Share	4,062 Added 6.46%	58,854 Common Shares
Jul 07 2025	SELL Open market or private sale	$9,746 $8.71 p/Share	1,119 Reduced 2.0%	54,792 Common Shares
Jul 07 2025	BUY Exercise of conversion of derivative security	$4,998 $2.35 p/Share	2,127 Added 3.66%	55,911 Common Shares
Apr 11 2025	SELL Open market or private sale	$6,974 $4.95 p/Share	1,409 Reduced 2.55%	53,784 Common Shares
Apr 11 2025	BUY Exercise of conversion of derivative security	$4,997 $2.3 p/Share	2,173 Added 3.79%	55,193 Common Shares
Feb 14 2025	SELL Open market or private sale	$8,088 $6.82 p/Share	1,186 Reduced 2.19%	53,020 Common Shares
Feb 14 2025	BUY Exercise of conversion of derivative security	$4,999 $2.51 p/Share	1,992 Added 3.54%	54,206 Common Shares
Dec 02 2024	SELL Open market or private sale	$39,351 $6.14 p/Share	6,409 Reduced 10.93%	52,214 Common Shares
Dec 02 2024	BUY Exercise of conversion of derivative security	$26,900 $2.69 p/Share	10,000 Added 14.57%	58,623 Common Shares
Oct 08 2024	SELL Open market or private sale	$6,369 $4.53 p/Share	1,406 Reduced 2.81%	48,623 Common Shares
Oct 08 2024	BUY Exercise of conversion of derivative security	$4,998 $2.55 p/Share	1,960 Added 3.77%	50,029 Common Shares
Jul 05 2024	SELL Open market or private sale	$7,073 $6.03 p/Share	1,173 Reduced 2.46%	46,457 Common Shares
Jul 05 2024	BUY Exercise of conversion of derivative security	$4,999 $2.79 p/Share	1,792 Added 3.63%	47,630 Common Shares
Apr 15 2024	SELL Open market or private sale	$8,360 $10.45 p/Share	800 Reduced 1.77%	44,449 Common Shares
Apr 15 2024	BUY Exercise of conversion of derivative security	$14,515 $10.45 p/Share	1,389 Added 2.94%	45,838 Common Shares
Mar 26 2024	SELL Open market or private sale	$23,190 $10.97 p/Share	2,114 Reduced 4.91%	40,920 Common Shares
Mar 26 2024	BUY Exercise of conversion of derivative security	$9,999 $2.31 p/Share	4,329 Added 8.73%	45,249 Common Shares
Dec 26 2023	SELL Open market or private sale	$15,151 $10.9 p/Share	1,390 Reduced 3.01%	44,788 Common Shares
Dec 26 2023	BUY Exercise of conversion of derivative security	$4,998 $1.59 p/Share	3,144 Added 6.37%	46,178 Common Shares
Nov 20 2023	SELL Open market or private sale	$2,219 $8.25 p/Share	269 Reduced 0.62%	43,034 Common Shares
Aug 18 2023	SELL Open market or private sale	$5,283 $7.85 p/Share	673 Reduced 1.53%	43,303 Common Shares
Jul 24 2023	SELL Open market or private sale	$55,523 $8.17 p/Share	6,796 Reduced 13.39%	43,976 Common Shares
Jul 24 2023	BUY Exercise of conversion of derivative security	$11,999 $0.72 p/Share	16,666 Added 24.71%	50,772 Common Shares
Jul 06 2023	SELL Open market or private sale	$18,693 $8.47 p/Share	2,207 Reduced 7.11%	28,826 Common Shares

CAR

Chris A Rallis

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FENC shares.

Notify only if

Value

Insider Trading

Get notified when an Fennec Pharmaceuticals Inc. insider buys or sells FENC shares.

Notify only if

Operation

Value

Type

News

Receive news related to FENNEC PHARMACEUTICALS INC.

Track Activities on FENC

Account